Authors:
BUESA JM
LOPEZPOUSA A
MARTIN J
ANTON A
DELMURO JG
BELLMUNT J
ARRANZ F
VALENTI V
ESCUDERO P
MENENDEZ D
CASADO A
POVEDA A
Citation: Jm. Buesa et al., PHASE-II TRIAL OF FIRST-LINE HIGH-DOSE IFOSFAMIDE IN ADVANCED SOFT-TISSUE SARCOMAS OF THE ADULT - A STUDY OF THE SPANISH GROUP FOR RESEARCHON SARCOMAS (GEIS), Annals of oncology, 9(8), 1998, pp. 871-876
Authors:
BUESA JM
FRA J
ANTON A
LOPEZPOUSA A
MARTIN J
DELMURO JG
ESCUDERO P
CASADO A
POVEDA A
Citation: Jm. Buesa et al., ACTIVITY OF DOXORUBICIN AFTER HIGH-DOSE IFOSFAMIDE IN ADULT PATIENTS WITH ADVANCED SOFT-TISSUE SARCOMA - A STUDY OF THE SPANISH GROUP FOR RESEARCH ON SARCOMAS (GEIS), Annals of oncology, 9(7), 1998, pp. 783-785
Authors:
LOPEZPOUSA A
MONTALAR J
BUESA J
MAUREL J
MARTIN J
CASSINELLO J
SEVILLA I
DELASPENAS R
CRUZ J
BALANA C
Citation: A. Lopezpousa et al., FIRST-LINE DOXORUBICIN AND HIGH-DOSE IFOSFAMIDE (DHI) IN ADVANCED SOFT-TISSUE SARCOMA (STS) PATIENTS - A PHASE-II STUDY OF THE SPANISH GROUP FOR RESEARCH ON SARCOMAS (GEIS), Annals of oncology, 9, 1998, pp. 564-564
Authors:
PUJOL RM
ROCAMORA V
LOPEZPOUSA A
TABERNER R
ALOMAR A
Citation: Rm. Pujol et al., PERSISTENT SUPRAVENOUS ERYTHEMATOUS ERUPTION - A RARE LOCAL COMPLICATION OF INTRAVENOUS 5-FLUOROURACIL THERAPY, Journal of the American Academy of Dermatology, 39(5), 1998, pp. 839-842
Authors:
DEANDRES L
BRUNET J
LOPEZPOUSA A
BURGUES J
VEGA M
TABERNERO JM
MESIA R
LOPEZ JJ
Citation: L. Deandres et al., RANDOMIZED TRIAL OF NEOADJUVANT CISPLATIN AND FLUOROURACIL VERSUS CARBOPLATIN AND FLUOROURACIL IN PATIENTS WITH STAGE IV-M0 HEAD AND NECK-CANCER, Journal of clinical oncology, 13(6), 1995, pp. 1493-1500
Authors:
DEANDRES L
LOPEZPOUSA A
BURGUES J
QUER M
LEON X
GUEDEA F
VEGA M
MESIA R
LOPEZ JJ
Citation: L. Deandres et al., FUNCTION PRESERVATION IN STAGE-III SQUAMOUS LARYNGEAL CARCINOMA - RESULTS WITH AN INDUCTION CHEMOTHERAPY PROTOCOL, The Laryngoscope, 105(8), 1995, pp. 822-826
Authors:
CARRIO I
LOPEZPOUSA A
ESTORCH M
DUNCKER D
BERNA L
TORRES G
DEANDRES L
Citation: I. Carrio et al., DETECTION OF DOXORUBICIN CARDIOTOXICITY IN PATIENTS WITH SARCOMAS BY INDIUM-111-ANTIMYOSIN MONOCLONAL-ANTIBODY STUDIES, The Journal of nuclear medicine, 34(9), 1993, pp. 1503-1507